Combination Cancer Therapy Modulators and Potentiators /
Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer T...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press,
2005.
|
| Series: | Cancer Drug Discovery and Development
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Targeting of the EGFR As a Modulator of Cancer Chemotherapy
- Cyclin-Dependent Kinase Inhibitors in Combination Chemotherapy
- Development of Protein Kinase C and Cyclin-Dependent Kinase Inhibitors As Potentiators of Cytotoxic Drug Action in Leukemia
- Carboxyamidotriazole, an Inhibitor of Nonvoltage-Operated Calcium Entry
- Targeted ?-Particle Therapy
- Pharmacological Modulation of Fluoropyrimidines
- Development of Inhibitors of HER2 With Taxanes
- Targeting NF-?B to Increase the Activity of Cisplatin in Solid Tumors
- Combinations of Chemotherapy and G3139, an Antisense Bcl-2 Oligonucleotide
- Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy.